Condition: Squamous Cell Carcinoma of the Oral Cavity · Squamous Cell Carcinoma of the Larynx · Squamous Cell Carcinoma of the Hypopharynx · Sponsor: University of Erlangen-Nürnberg Medical School
This randomized, prospective, multicenter phase II/III trial will study the reduction of radiation volume by eliminating radiotherapy (RT) to the elective neck using strictly defined surgical and radio-oncological standards to reduce radiotherapy-related long-term side effects without affecting locoregional control.
This description comes directly from the study's public registry record.
Marlen Haderlein, PD · +49913185 · marlen.haderlein@uk-erlangen.de
Studiensekretariat · +49913185 · studiensekretariat.ST@uk-erlangen.de
Always discuss trial participation with your own doctor first.
| Universitätsklinikum Erlangen, Strahlenklinik | Erlangen, Bavaria, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06030440